AstraZeneca plc stock price

<p><span style="font-weight: 400;">AstraZeneca is a multinational that operates as a pharmaceutical and biopharmaceutical company. The company’s roots date back to 1913 when it was founded as Astra AB by 400 doctors in Sweden. In 1999, Astra AB merged with British Zeneca Group resulting in the formation of AstraZeneca</span></p> <p><span style="font-weight: 400;">Headquartered in Cambridge, United Kingdom, the company is engaged in the development and commercialization of medicines. The company focuses on oncology cardiovascular, respiratory treatments, among others. Some of its leads products include Tagrisso and Nolvadex.</span></p> <p><span style="font-weight: 400;">Just like other giant pharmaceuticals, it has grown through acquisitions. Its notable acquisitions include Spurge for $440 million and Bristol Myers Squibb for $3.4 billion. In 2017, the company rejected a $117 billion takeover bid by Pfizer. A merger of the two would have resulted in the world&#8217;s biggest drugmaker.</span></p> <p><span style="font-weight: 400;">The pharmaceutical company is currently listed in the New York Stock Exchange as well as the London Stock Exchange and OMX Exchange.</span></p>